1. BRAIN FOG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, AND ASSOCIATION WITH USE OF PROBIOTICS. (22nd January 2022) Authors: Dadlani, Apaar; Gala, Khushboo; Rai, Jayesh; Rai, Shesh; Dryden, Gerald Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Computed Tomography Colonography: The Robley Rex VAMC Experience: 237. (October 2016) Authors: Henry, LaTasha; Ahmed, Shifat; Pontikos, Alexander; Dryden, Gerald Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of Gastric Neuromodulation on Crohn's Disease in Patients With Coexisting Symptoms of Gastroparesis. Issue 8 (18th February 2020) Authors: Bhatti, Sundus; Jaafar, Imad; Hassan, Hamza; Atassi, Hadi; Stocker, Abigail; Hughes, Michael; Pinkston, Christina; Dryden, Gerald; Abell, Thomas Journal: Neuromodulaton Issue: Volume 23:Issue 8(2020) Page Start: 1196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022) Authors: Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022) Authors: Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis. (11th May 2017) Authors: Liu, Liming; Zhao, Cuiqing; Yang, Ying; Kong, Xiaoxia; Shao, Tuo; Ren, Li; Zhuang, Xinyu; Yin, Baishuang; Dryden, Gerald; McClain, Craig; Luan, Weimin; Feng, Wenke Other Names: Pagnini Cristiano Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation. Issue 6 (August 2017) Authors: Mehta, Minesh; Ahmed, Shifat; Dryden, Gerald Journal: Innate immunity Issue: Volume 23:Issue 6(2017:Aug.) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-105 The Effect of Vedolizumab on Extraintestinal Manifestations in Patients with Crohn's Disease in GEMINI 2. (March 2016) Authors: Rubin, David; Feagan, Brian; Dryden, Gerald; Melmed, Gil; Lasch, Karen; Abhyankar, Brihad; Xu, Jing; James, Alexandra; Thiny, Michelle Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-105 The Effect of Vedolizumab on Extraintestinal Manifestations in Patients with Crohn's Disease in GEMINI 2. (March 2016) Authors: Rubin, David; Feagan, Brian; Dryden, Gerald; Melmed, Gil; Lasch, Karen; Abhyankar, Brihad; Xu, Jing; James, Alexandra; Thiny, Michelle Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-145 Oral Administration of EGCG, a Green Tea Polyphenol, Both Suppresses and Rescues Mice from DSS-Induced Colitis. (March 2016) Authors: Stillman, Andrew; Connors, Michael; Miller, Matthew; Qazzaz, Hassan; Dryden, Gerald Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗